Vikash Biotec Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 10-12-2024
- Paid Up Capital ₹ 1.48 M
as on 10-12-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.84 Cr
as on 10-12-2024
- Satisfied Charges ₹ 4.50 Cr
as on 10-12-2024
- Revenue -4.23%
(FY 2022)
- Profit 18.64%
(FY 2022)
- Ebitda -9.12%
(FY 2022)
- Net Worth 5.73%
(FY 2022)
- Total Assets 3.41%
(FY 2022)
About Vikash Biotec
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 1.48 M.
The company currently has active open charges totaling ₹7.84 Cr. The company has closed loans amounting to ₹4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vikash Mohta and Pradip Mohta serve as directors at the Company.
- CIN/LLPIN
U24239WB2004PTC098352
- Company No.
098352
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vikash Biotec?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikash Mohta  | Director | 19-Apr-2004 | Current |
| Pradip Mohta | Director | 01-Aug-2017 | Current |
Financial Performance and Corporate Structure Insights of Vikash Biotec.
Vikash Biotec Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.23% decrease. The company also saw a substantial improvement in profitability, with a 18.64% increase in profit. The company's net worth moved up by a moderate rise of 5.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vikash Biotec?
Unlock access to Vikash Biotec's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Think Box Solutions Private LimitedActive 17 years 10 monthsVikash Mohta and Pradip Mohta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 05 Sep 2022 | ₹7.84 Cr | Open |
The South Indian Bank Limited Creation Date: 07 Mar 2018 | ₹4.10 Cr | Satisfied |
State Bank Of India Creation Date: 15 Mar 2010 | ₹4.00 M | Satisfied |
How Many Employees Work at Vikash Biotec?
Unlock and access historical data on people associated with Vikash Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vikash Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vikash Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
